NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Initial Phase 1/2 data presented at the 63rd American Society of Hematology (ASH) Annual Meeting and ExpositionPhase 1/2 study of NEXI-002 as a monotherapy.